Clinical Trial Update: The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and preliminary effectiveness of a two-drug combination in patients co-infected with hepatitis C and advanced HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatitis C | Phase 1 | Status: COMPLETED